Newest first
New topics page 38
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 38 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: How much fluid is actually needed, and how you would know
How much fluid is actually needed, and how you would know — that is the question, and I have not found it answered plainly anywhere I have looked. Maintenance rather than loss, which is the part of this that…
|
+17 | 21 | 12k | 13mo |
|
Payment mechanics and the recovery options that do not exist — what changed since
On the subject in the title: Payment mechanics and the recovery options that do not exist — what changed since Working notes rather than a conclusion. A logistics question, since the answers here are usually…
|
+14 | 18 | 17k | 13mo |
|
Storing a pen in use versus a pen unopened — what changed since
Posting this under the heading it deserves: Storing a pen in use versus a pen unopened — what changed since Everything below is what sits behind that. I have read the maintained page on this and I still have…
|
2 | 206 | 15mo | |
|
One lot is one lot: when a report becomes a pattern — the long version
One lot is one lot: when a report becomes a pattern — the long version — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the…
|
+137 | 152 | 46k | 16mo |
|
Follow-up: Review cadence: how often is a page actually re-checked?
The question in the title: Review cadence: how often is a page actually re-checked? I will give what I have already checked below so nobody repeats it. Nominating something for promotion into the…
|
2 | 64k | 16mo | |
|
Why the timeline is on the right and not the left
Why the timeline is on the right and not the left — that is the question, and I have not found it answered plainly anywhere I have looked. Nominating something for promotion into the documentation commons.…
|
+67 | 73 | 19k | 10mo |
|
The C-cell question: rodent findings and their human context
Posting this under the heading it deserves: The C-cell question: rodent findings and their human context Everything below is what sits behind that. I have seen STEP 8 ( JAMA , 2022) cited in support of a…
|
+41 | 45 | 24k | 12mo |
|
Counter-ion content and its effect on measured mass
On the subject in the title: Counter-ion content and its effect on measured mass Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked. retatrutide has a…
|
+100 | 108 | 45k | 12mo |
|
Coverage for the indication versus for the drug
Coverage for the indication versus for the drug — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+70 | 79 | 18k | 14mo |
|
Second pass at: Pen dose counters: what a click does and does not guarantee
Second pass at: Pen dose counters: what a click does and does not guarantee — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been…
|
+63 | 68 | 51k | 13mo |
|
Maintainer handover: how it works
On the subject in the title: Maintainer handover: how it works Working notes rather than a conclusion. Process question about how this site works. I have read the guidelines and the trust-level page and I…
|
+76 | 82 | 14k | 16mo |
|
About the Progress reports category
Longitudinal self-reports with the method stated. Scales, tape measures, and their error bars. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
|
4 | 139 | 16mo | |
|
Hepatic steatosis: what the MASH trial evidence supports
Hepatic steatosis: what the MASH trial evidence supports — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in…
|
+77 | 83 | 950 | 13mo |
|
Follow-up: Journal club: the retatrutide phase 2 obesity paper
On the subject in the title: Journal club: the retatrutide phase 2 obesity paper Working notes rather than a conclusion. I have seen SURMOUNT-1 ( N Engl J Med , 2022) cited in support of a claim I do not…
|
+20 | 24 | 8.7k | 16mo |
|
Why one laboratory's 98.4% and another's 96.1% may not contradict
Why one laboratory's 98.4% and another's 96.1% may not contradict I have a specific reason for asking rather than idle curiosity, and the context is below. A documentation question rather than an analytical…
|
+28 | 37 | 457 | 7mo |
|
Retatrutide dose escalation in the published trials
Posting this under the heading it deserves: Retatrutide dose escalation in the published trials Everything below is what sits behind that. Session topic: SURPASS-2 ( N Engl J Med , 2021). Please read it…
|
+149 | 159 | 30k | 15mo |
|
What to keep a record of at the point of payment
What to keep a record of at the point of payment — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the…
|
2 | 1.8k | 16mo | |
|
Why plausible mechanism is not evidence of effect
Asking directly, because I could not find a straight answer: Why plausible mechanism is not evidence of effect Session topic: STEP 2 ( Lancet , 2021). Please read it before posting; the discussion is much…
|
+14 | 18 | 57k | 13mo |
|
Coming back to: Sample size calculations, read backwards from the published number
On the subject in the title: Sample size calculations, read backwards from the published number Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before…
|
+82 | 88 | 1.8k | 11mo |
|
Certificates issued by the seller versus by a laboratory
Posting this under the heading it deserves: Certificates issued by the seller versus by a laboratory Everything below is what sits behind that. I would like to understand what this number means before I…
|
+58 | 65 | 1.2k | 15mo |
|
Pen wastage and its effect on real cost — the long version
Posting this under the heading it deserves: Pen wastage and its effect on real cost — the long version Everything below is what sits behind that. Documenting an access outcome, dated, because everything in…
|
2 | 34k | 13mo | |
|
Severe gastroparesis and why this class is a poor fit
On the subject in the title: Severe gastroparesis and why this class is a poor fit Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in this…
|
3 | 62k | 13mo | |
|
Second pass at: Retatrutide mass and identity: what a report should show
Second pass at: Retatrutide mass and identity: what a report should show — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with STEP 4 ( JAMA , 2021)…
|
+65 | 71 | 4.6k | 13mo |
|
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset
Posting this under the heading it deserves: Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with FLOW…
|
+58 | 64 | 17k | 13mo |
|
Follow-up: Is "synergy" the right word for the combination data?
Is "synergy" the right word for the combination data? I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a…
|
2 | 41k | 14mo | |
|
Requesting a translation of an existing page
Requesting a translation of an existing page — setting out what I have, and where I think it stops being reliable. Process question about how this site works. I have read the guidelines and the trust-level…
|
+16 | 20 | 7.1k | 14mo |
|
Antibiotics and a course of something with delayed emptying
Antibiotics and a course of something with delayed emptying — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern is useful…
|
+99 | 108 | 1.4k | 12mo |
|
Splitting a vial for two laboratories: how to do it without ruining both
Splitting a vial for two laboratories: how to do it without ruining both — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better…
|
+64 | 70 | 4.4k | 13mo |
|
Particulates in a reconstituted solution: identifying the likely source — what changed since
Particulates in a reconstituted solution: identifying the likely source — what changed since — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what…
|
2 | 129 | 14mo | |
|
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med ,…
|
+81 | 90 | 54k | 9mo |